Skip to main content
Erschienen in: Heart and Vessels 7/2016

29.05.2015 | Case Report

Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks

verfasst von: Minoru Tagawa, Sachie Ochiai, Yuichi Nakamura, Akinori Sato, Masaomi Chinushi

Erschienen in: Heart and Vessels | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

A 73-year-old woman first visited our emergency room with multiple syncopal attacks. Before admission, she had received an antibiotic (Garenoxacin) for 3 days from a local clinic. First electrocardiogram (ECG) showed no ST-segment deviation but mild QT interval prolongation with a positive U wave. Second ECG recording 3 h later showed slightly slower heart rate and revealed marked QTU interval prolongation suggesting the cause of her syncopal attacks. After cessation of Garenoxacin, the QTU interval prolongation shortened. However, both epinephrine infusion and treadmill exercise test reproduced similar QTU interval prolongation and T wave deformities. Later, genetic analysis demonstrated that this patient had a mutation in KCNH2 gene, and she was diagnosed as a type-2 long-QT syndrome which was accentuated by use of garenoxacin. At the emergency out-patient clinic, repetitive ECG recordings can be useful and should be considered in order to identify the cause of syncopal attacks in patients who were prescribed antibiotics and had mild QT interval abnormalities.
Literatur
1.
Zurück zum Zitat Brignole M, Hamdan MH (2012) New concepts in the assessment of syncope. J Am Coll Cardiol 59:1583–1591CrossRefPubMed Brignole M, Hamdan MH (2012) New concepts in the assessment of syncope. J Am Coll Cardiol 59:1583–1591CrossRefPubMed
2.
Zurück zum Zitat Task force for the diagnosis and management of syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671CrossRef Task force for the diagnosis and management of syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671CrossRef
4.
Zurück zum Zitat Schwartz PJ, Ackerman MJ (2013) The long-QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 34:3109–3116CrossRefPubMed Schwartz PJ, Ackerman MJ (2013) The long-QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 34:3109–3116CrossRefPubMed
5.
Zurück zum Zitat Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W, Sata M (2014) Congenital long-QT syndrome with compound mutations in the KCNH2 gene. Heart Vessels 29(4):554–559CrossRefPubMed Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W, Sata M (2014) Congenital long-QT syndrome with compound mutations in the KCNH2 gene. Heart Vessels 29(4):554–559CrossRefPubMed
6.
Zurück zum Zitat Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM (2010) Causes and management of drug-induced long-QT syndrome. Proc (Bayl Univ Med Cent) 23:250–255 Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM (2010) Causes and management of drug-induced long-QT syndrome. Proc (Bayl Univ Med Cent) 23:250–255
8.
Zurück zum Zitat Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, Goldstein SA (2000) A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 97(19):10613–10618CrossRefPubMedPubMedCentral Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, Goldstein SA (2000) A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 97(19):10613–10618CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Anderson ME, Mazur A, Yang T, Roden DM (2001) Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J Pharmacol Exp Ther 296(3):806–810PubMed Anderson ME, Mazur A, Yang T, Roden DM (2001) Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J Pharmacol Exp Ther 296(3):806–810PubMed
10.
Zurück zum Zitat Alexandrou AJ, Duncan RS, Sullivan A, Hancox JC, Leishman DJ, Witchel HJ, Leaney JL (2006) Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotics moxifloxacin. Br J Pharmacol 147:905–916CrossRefPubMedPubMedCentral Alexandrou AJ, Duncan RS, Sullivan A, Hancox JC, Leishman DJ, Witchel HJ, Leaney JL (2006) Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotics moxifloxacin. Br J Pharmacol 147:905–916CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM (2003) Multiple-dose safety and pharmacokinetic of oral garenoxacin in healthy subjects. Antimicrob Agents Chemother 47(7):2256–2263CrossRefPubMedPubMedCentral Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM (2003) Multiple-dose safety and pharmacokinetic of oral garenoxacin in healthy subjects. Antimicrob Agents Chemother 47(7):2256–2263CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799CrossRefPubMed Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799CrossRefPubMed
13.
Zurück zum Zitat Shimizu W, Horie M (2011) Phenotypic manifestations of mutations in genes encoding subunit of cardiac potassium channels. Circ Res 109:97–109CrossRefPubMed Shimizu W, Horie M (2011) Phenotypic manifestations of mutations in genes encoding subunit of cardiac potassium channels. Circ Res 109:97–109CrossRefPubMed
14.
Zurück zum Zitat Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S (2009) Genotype-phenotype aspects of type 2 long-QT syndrome. J Am Coll Cardiol 54(22):2052–2062CrossRefPubMedPubMedCentral Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S (2009) Genotype-phenotype aspects of type 2 long-QT syndrome. J Am Coll Cardiol 54(22):2052–2062CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mihic A, Chauhan VS, Gao X, Oudit GY, Tsushima RG (2011) Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long-QT syndrome mutation. PLoS ONE 6(3):e18273CrossRefPubMedPubMedCentral Mihic A, Chauhan VS, Gao X, Oudit GY, Tsushima RG (2011) Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long-QT syndrome mutation. PLoS ONE 6(3):e18273CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Liu L, Hayashi K, Kaneda T, Ino H, Fujino N, Uchiyama K, Konno T, Tsuda T, Kawashiri MA, Ueda K, Higashikata T, Shuai W, Kupershmidt S, Higashida H, Yamagishi M (2013) A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long-QT syndrome. Heart Rhythm 10(1):61–67CrossRefPubMed Liu L, Hayashi K, Kaneda T, Ino H, Fujino N, Uchiyama K, Konno T, Tsuda T, Kawashiri MA, Ueda K, Higashikata T, Shuai W, Kupershmidt S, Higashida H, Yamagishi M (2013) A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long-QT syndrome. Heart Rhythm 10(1):61–67CrossRefPubMed
17.
Zurück zum Zitat Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95CrossRefPubMed Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95CrossRefPubMed
18.
Zurück zum Zitat Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD (2010) Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 3(2):120–125CrossRefPubMed Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD (2010) Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 3(2):120–125CrossRefPubMed
19.
Zurück zum Zitat Clur SA, Chockalingam P, Filippini LH, Widyanti AP, Van Cruijsen M, Blom NA, Alders M, Hofman N, Wilde AA (2010) The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long-QT syndrome. Pediatr Cardiol 31(4):462–468CrossRefPubMed Clur SA, Chockalingam P, Filippini LH, Widyanti AP, Van Cruijsen M, Blom NA, Alders M, Hofman N, Wilde AA (2010) The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long-QT syndrome. Pediatr Cardiol 31(4):462–468CrossRefPubMed
20.
Zurück zum Zitat Toyota N, Miyazaki A, Sakaguchi H, Shimizu W, Ohuchi H (2014) A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers. Heart Vessels. doi:10.1007/s00380-014-0530-7 PubMed Toyota N, Miyazaki A, Sakaguchi H, Shimizu W, Ohuchi H (2014) A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers. Heart Vessels. doi:10.​1007/​s00380-014-0530-7 PubMed
21.
Zurück zum Zitat Vyas H, Hejlik J, Ackerman MJ (2006) Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical response. Circulation 113(11):1385–1392CrossRefPubMed Vyas H, Hejlik J, Ackerman MJ (2006) Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical response. Circulation 113(11):1385–1392CrossRefPubMed
22.
Zurück zum Zitat Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long-QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long-QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed
23.
Zurück zum Zitat Hekkala AM, Viitasalo M, Väänänen H, Swan H, Toivonen L (2010) Abnormal repolarization dynamics revealed in exercise test in long-QT syndrome mutation carriers with normal resting QT interval. Europace 12(9):1296–1301CrossRefPubMed Hekkala AM, Viitasalo M, Väänänen H, Swan H, Toivonen L (2010) Abnormal repolarization dynamics revealed in exercise test in long-QT syndrome mutation carriers with normal resting QT interval. Europace 12(9):1296–1301CrossRefPubMed
24.
Zurück zum Zitat Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, Hedley P, Heradien M, Bacchini S, Turco A, La Rovere MT, Bartoli A, George AL Jr, Brink PA (2008) Neural control of heart rate is an arrhythmia risk modifier in long-QT syndrome. J Am Coll Cardiol 51(9):920–929CrossRefPubMed Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, Hedley P, Heradien M, Bacchini S, Turco A, La Rovere MT, Bartoli A, George AL Jr, Brink PA (2008) Neural control of heart rate is an arrhythmia risk modifier in long-QT syndrome. J Am Coll Cardiol 51(9):920–929CrossRefPubMed
25.
Zurück zum Zitat Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M (2010) Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 12(11):1623–1629CrossRefPubMed Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M (2010) Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 12(11):1623–1629CrossRefPubMed
26.
Zurück zum Zitat Fossa AA (2008) The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol 154(7):1508–1515CrossRefPubMedPubMedCentral Fossa AA (2008) The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol 154(7):1508–1515CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Fujiki A, Yoshioka R, Sakabe M (2015) Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels 30(2):235–240CrossRefPubMed Fujiki A, Yoshioka R, Sakabe M (2015) Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels 30(2):235–240CrossRefPubMed
28.
Zurück zum Zitat Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B (2006) Corrected QT variability in serial electrocardiograms in long-QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48(5):1047–1052CrossRefPubMed Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B (2006) Corrected QT variability in serial electrocardiograms in long-QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48(5):1047–1052CrossRefPubMed
Metadaten
Titel
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks
verfasst von
Minoru Tagawa
Sachie Ochiai
Yuichi Nakamura
Akinori Sato
Masaomi Chinushi
Publikationsdatum
29.05.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 7/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0693-x

Weitere Artikel der Ausgabe 7/2016

Heart and Vessels 7/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.